ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,877 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryPrattelnSanthera Pharmaceuticals (Schweiz) AG
Santhera Pharmaceuticals (Schweiz) AG Logo
Verified· 4 sources

Santhera Pharmaceuticals (Schweiz) AG

Summary

About the company

Santhera Pharmaceuticals (Schweiz) AG develops and commercializes medicines for patients with rare and other diseases that have high unmet medical needs. The company focuses on developing treatments for neuromuscular disorders, such as Duchenne muscular dystrophy.

AI-generated
Offering
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Products & services

Industry:Pharmaceutical Industry
✓ Offered4
Medicines for rare neuromuscular and pulmonary diseases
Development of treatments for rare diseases, in particular neuromuscular and pulmonary diseases with unmet medical need.
AGAMREE® (vamorolone)
AGAMREE® (vamorolone) for the treatment of Duchenne muscular dystrophy; described on the website with approval status, product information and ordering instructions for pharmacies.
Scientific publications and clinical information
Scientific publications, clinical studies and medical information on AGAMREE® and the development programme with vamorolone.
Career positions
Open positions and career information for employees in an international environment of medical science.
Reviews

Aggregated rating

Aggregated rating
4.7
of 5

Aggregated from 3 reviews across all connected sources

Sources
GGoogle4.73
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

January 8, 2026Media
Aktie von Santhera vollzieht Kurssprung nach Lizenzvereinbarung für Medikament Agamree
cash.ch

Knowledge

No knowledge articles yet

Once Santhera Pharmaceuticals (Schweiz) AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Santhera Pharmaceuticals (Schweiz) AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Santhera Pharmaceuticals (Schweiz) AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Santhera Pharmaceuticals (Schweiz) AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hohenrainstrasse 24
4133 Pratteln

At a glance

Legal form
Corporation
UID
CHE-112.001.828
Founded
2004 · 22 years
Last commercial register change
April 8, 2025
Employees
21 to 50

Similar companies

NP
Novartis Pharma Schweizerhalle AG
Pratteln
WA
Weleda AG
Arlesheim
GP
Gebro Pharma AG
Liestal
AP
Abbott Products Operations AG
Allschwil